Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Uchida

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Obstetric Anesthesia|January 26, 2006
Anesthetic management for cesarean section in moyamoya disease: a report of five consecutive cases and a mini-reviewR Kato, K Terui, K Yokota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer]J Uchida, H Satake, H Saito, et al.
European Urology|January 1, 1994
Laparoscopic ureterolysis for idiopathic retroperitoneal fibrosisT Matsuda, Y Arai, K Muguruma, et al.
Rinsho Hoshasen. Clinical Radiography|September 1, 1981
[Roentgenologic diagnosis of smooth-muscle tumors with extraluminal growth of the small intestine (author's transl)]K Ishihara, T Kano, N Hisamoto, et al.
Anticancer Research|August 11, 2001
Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracilT Kato, Y Shimamoto, J Uchida, et al.
Transplantation Proceedings|March 25, 2014
Investigation of urinary angiotensinogen in renal transplant recipientsT Naganuma, Y Takemoto, S Maeda, et al.
Transplantation Proceedings|February 8, 2012
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolismJ Uchida, N Kuwabara, Y Machida, et al.
British Journal of Cancer|September 19, 2025
Retraction Note: Identification of thymidylate synthase as a potential therapeutic target for lung cancerK Takezawa, I Okamoto, S Tsukioka, et al.
Anti-Cancer Drugs|December 5, 1998
Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracilM Fukushima, Y Shimamoto, T Kato, et al.
British Journal of Cancer|July 15, 2010
Identification of thymidylate synthase as a potential therapeutic target for lung cancerK Takezawa, I Okamoto, S Tsukioka, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Obstetric Anesthesia|January 26, 2006
Anesthetic management for cesarean section in moyamoya disease: a report of five consecutive cases and a mini-reviewR Kato, K Terui, K Yokota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer]J Uchida, H Satake, H Saito, et al.
European Urology|January 1, 1994
Laparoscopic ureterolysis for idiopathic retroperitoneal fibrosisT Matsuda, Y Arai, K Muguruma, et al.
Rinsho Hoshasen. Clinical Radiography|September 1, 1981
[Roentgenologic diagnosis of smooth-muscle tumors with extraluminal growth of the small intestine (author's transl)]K Ishihara, T Kano, N Hisamoto, et al.
Anticancer Research|August 11, 2001
Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracilT Kato, Y Shimamoto, J Uchida, et al.
Transplantation Proceedings|March 25, 2014
Investigation of urinary angiotensinogen in renal transplant recipientsT Naganuma, Y Takemoto, S Maeda, et al.
Transplantation Proceedings|February 8, 2012
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolismJ Uchida, N Kuwabara, Y Machida, et al.
British Journal of Cancer|September 19, 2025
Retraction Note: Identification of thymidylate synthase as a potential therapeutic target for lung cancerK Takezawa, I Okamoto, S Tsukioka, et al.
Anti-Cancer Drugs|December 5, 1998
Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracilM Fukushima, Y Shimamoto, T Kato, et al.
British Journal of Cancer|July 15, 2010
Identification of thymidylate synthase as a potential therapeutic target for lung cancerK Takezawa, I Okamoto, S Tsukioka, et al.
Pageof 13